These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 30541507

  • 1. A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
    Noto T, Seto H, Fukuhara J, Murabayashi M, Yachie A, Ayusawa M, Morioka I.
    BMC Pediatr; 2018 Dec 12; 18(1):386. PubMed ID: 30541507
    [Abstract] [Full Text] [Related]

  • 2. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.
    Takahara T, Shimizu M, Nakagishi Y, Kinjo N, Yachie A.
    Rheumatol Int; 2015 Jan 12; 35(1):81-4. PubMed ID: 24917023
    [Abstract] [Full Text] [Related]

  • 3. Anakinra and hepatotoxicity in pediatric rheumatology: a case series.
    Martins FR, Azevedo AC, Ganhão S, Aguiar F, Rodrigues M, Brito I.
    Pediatr Rheumatol Online J; 2023 Oct 06; 21(1):112. PubMed ID: 37803456
    [Abstract] [Full Text] [Related]

  • 4. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S, Liu Y, Yan W, Zhang T, Wang P, Zhu M, Zhang X, Zhou P, Fan Z, Yu H.
    Pediatr Rheumatol Online J; 2024 May 23; 22(1):58. PubMed ID: 38783316
    [Abstract] [Full Text] [Related]

  • 5. Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease.
    Mizuta M, Shimizu M, Inoue N, Kasai K, Nakagishi Y, Takahara T, Hamahira K, Yachie A.
    Mod Rheumatol; 2016 Nov 23; 26(6):929-932. PubMed ID: 27433933
    [Abstract] [Full Text] [Related]

  • 6. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G, Paç Kısaarslan A, Ulu K, Atalay E, Haşlak F, Özdel S, Bozkaya Yücel B, Gezgin Yıldırım D, Çakmak F, Öztürk K, Çakan M, Balık Z, Hasbal Akkuş C, Yıldız M, Erat T, Çetin BŞ, Yılmaz M, Bağlan E, Laçinel Gürlevik S, Atasayan V, Karadağ ŞG, Adrovic A, Çağlayan Ş, Tanatar A, Demirkan FG, Coşkuner T, Akgün Ö, Kasap Cüceoğlu M, Kavrul Kayaalp G, Şahin S, Başaran Ö, Demir F, Barut K, Çiftel M, Gürses D, Baykan A, Özsürekçi Y, Karagöz T, Sönmez HE, Bilginer Y, Aktay Ayaz N, Aydoğ Ö, Yüksel S, Sözeri B, Kasapçopur Ö, Özen S.
    Rheumatol Int; 2022 May 23; 42(5):879-889. PubMed ID: 34491393
    [Abstract] [Full Text] [Related]

  • 7. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX, Zhu Y, Sun L, Ma HH, Yang SR, Zeng HS, Xiao JH, Yu HG, Guo L, Xu YP, Lu MP.
    World J Pediatr; 2020 Feb 23; 16(1):89-98. PubMed ID: 31612427
    [Abstract] [Full Text] [Related]

  • 8. Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases.
    Xia Y, Cui P, Li Q, Liang F, Li C, Yang J.
    Braz J Med Biol Res; 2017 Feb 16; 50(2):e5958. PubMed ID: 28225869
    [Abstract] [Full Text] [Related]

  • 9. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA.
    Ann Rheum Dis; 2020 Feb 16; 79(2):225-231. PubMed ID: 31707357
    [Abstract] [Full Text] [Related]

  • 10. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Yasin S, Fall N, Brown RA, Henderlight M, Canna SW, Girard-Guyonvarc'h C, Gabay C, Grom AA, Schulert GS.
    Rheumatology (Oxford); 2020 Feb 01; 59(2):361-366. PubMed ID: 31326996
    [Abstract] [Full Text] [Related]

  • 11. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, Hirsch R.
    J Rheumatol; 2013 Jul 01; 40(7):1191-9. PubMed ID: 23678162
    [Abstract] [Full Text] [Related]

  • 12. Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels.
    Cunha BA, Pherez FM, Alexiadis V, Gagos M, Strollo S.
    Heart Lung; 2010 Jul 01; 39(2):164-72. PubMed ID: 20207278
    [Abstract] [Full Text] [Related]

  • 13. Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease.
    Kim SH, Song ES, Yoon S, Eom GH, Kang G, Cho YK.
    Ann Lab Med; 2021 May 01; 41(3):318-322. PubMed ID: 33303717
    [Abstract] [Full Text] [Related]

  • 14. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
    Guo L, Xu Y, Qian X, Zou L, Zheng R, Teng L, Zheng Q, Leung Jung LK, Lu M.
    J Pediatr; 2021 Aug 01; 235():203-211.e3. PubMed ID: 33581106
    [Abstract] [Full Text] [Related]

  • 15. A Case of Kawasaki Disease with Intussusception.
    Ueharu K, Asano T, Fukunaga R, Matsui R, Yoshida K, Miyatake-Sudoh C, Abe M, Fujita A, Ito Y.
    J Nippon Med Sch; 2021 Jan 08; 87(6):346-349. PubMed ID: 32612012
    [Abstract] [Full Text] [Related]

  • 16. Overlapping clinical features of systemic juvenile idiopathic arthritis and SARS-CoV-2-related multisystem inflammatory syndrome in children.
    Boyarchuk O, Kovalchuk T.
    Reumatologia; 2023 Jan 08; 61(1):63-70. PubMed ID: 36998579
    [Abstract] [Full Text] [Related]

  • 17. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
    Mizuta M, Shimizu M, Irabu H, Usami M, Inoue N, Nakagishi Y, Wada T, Yachie A.
    Rheumatology (Oxford); 2021 Jan 05; 60(1):231-238. PubMed ID: 32681176
    [Abstract] [Full Text] [Related]

  • 18. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Likhacheva TS, Isupova EA, Glebova NI, Kuchinskaya EM, Balbotkina EV, Buchinskaya NV, Kalashnikova OV, Chasnyk VG.
    Semin Arthritis Rheum; 2015 Feb 05; 44(4):417-22. PubMed ID: 25300700
    [Abstract] [Full Text] [Related]

  • 19. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
    Çakan M, Karadağ ŞG, Tanatar A, Ayaz NA.
    Mod Rheumatol; 2020 Sep 05; 30(5):900-904. PubMed ID: 31462146
    [Abstract] [Full Text] [Related]

  • 20. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A, Marasco E, Marucci G, Pardeo M, Insalaco A, Caiello I, Moneta GM, Prencipe G, De Benedetti F, Bracaglia C.
    Pediatr Rheumatol Online J; 2019 May 22; 17(1):25. PubMed ID: 31118063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.